Prozeller, D., Rosenauer, C., Morsbach, S
weight loss at target dose (trial data) ~6% CV risk reduction labelled Yes (T2D + CVD) Format Prefilled FlexTouch pen India price (May 2026) 5,6609,100/month DCGI-approved Yes (pre-2026) Generic competition in India n/a (innovator) Wegovy Novo Nordisk semaglutide Active molecule Semaglutide Receptor activity GLP-1 Primary indication Chronic weight management Max maintenance dose 2.4 mg weekly Avg
If you experience severe pain, persistent swelling, or signs of infection (warmth, pus, increasing redness), contact PlexusDx or seek medical attention
Effortless Application:Simply peel and apply one patch to clean, dry skin with minimal hair
If you have specific concerns about muscle loss or want a personalized treatment plan informed by genetic testing, PlexusDx clinicians can review your individual risk factors and adjust your semaglutide strategy accordingly
The combination of pipetting and forcing sample volume through the micro-column in place at the distal end of a pipette tip provides enhancement of the enrichment process due to microfluidics, resulting in shorter incubation times